Over 200 national and international civil society organisations from around the world have signed a letter to the leadership of the European Commission and EU…
actionsantemondiale29 June 2021
Cooperation for development EU, Immunization, Promoting transparent and needs-driven EU R&D policies, Research and Development
On June 9, the European Parliament will have the chance to vote in favor of using a tool that will allow us all to end…
actionsantemondiale8 June 2021
Press Release GHA welcomes the up-coming Rome Declaration and the efforts of G20 leaders to set principles and guiding commitments to serve as orientation for…
actionsantemondiale20 May 2021
Press Release The statement provoked a series of reactions from many high-level officials from European governments, including Germany*, Spain, Italy, Ireland, Sweden and the Netherlands.…
actionsantemondiale6 May 2021
On 15 April 2020, on the occasion of the first anniversary of ACT-Accelerator, Global Health Advocates organised an online event to discuss France’s and the…
actionsantemondiale29 April 2021
Press release The European Commission and European Union (EU) Member States continue to ignore growing calls for a patent waiver that would increase global production…
actionsantemondiale27 April 2021
Position paper While it is important to learn from our mistakes and begin preparing for the next health crisis, we must not forget that we…
actionsantemondiale27 April 2021
The European Commission has proposed nine new partnerships, mostly public-private, under the EU's flagship research funding program - Horizon Europe. One of them is the…
actionsantemondiale14 April 2021
Covid-19, Promoting transparent and needs-driven EU R&D policies, Promoting transparent and needs-driven French R&D policies
On 13th April, GHA and more than 240 CSOs signed a letter addressed to Director General of the World Trade Organisation Dr. Ngozi Okonjo-Iweala, calling…
actionsantemondiale13 April 2021
Alors que les derniers indicateurs relatifs à la santé des femmes témoignent de l'impact considérable qu'a le Covid-19 sur la santé sexuelle et reproductive, Action…
@dm1n1str@t0r2 February 2021
Alors que les derniers indicateurs relatifs à la santé des femmes témoignent de l'impact considérable qu'a le Covid-19 sur la santé sexuelle et reproductive, Action…
@dm1n1str@t0r1 February 2021
Aligned with our first support through the open letter signed by more than 500 organisations, GHA and more than 100 civil society organisations are now…
@dm1n1str@t0r19 November 2020
If the COVID-19 pandemic could teach us just one lesson, let it be that we - the international community - must be better prepared to…
@dm1n1str@t0r24 July 2020
A response to the Innovative Medicines Initiative’s open letter 10/07/2020 On May 25th, Corporate Europe Observatory and Global Health Advocates published two investigative reports on…
@dm1n1str@t0r10 July 2020
Noting the special challenges of the COVID-19 global pandemic, GHA welcomes the “Next Generation EU” recovery package, and the revised 7 year budget proposal, which…
@dm1n1str@t0r29 June 2020
On June 4th, 2020, the UK hosted the replenishment of Gavi, the Vaccine Alliance, providing an the international community to realign with the ambitions of…
@dm1n1str@t0r5 June 2020
This article is an updated version of a case study contained in the report "More Private than Public – The ways Big Pharma dominates the Innovative Medicines…
@dm1n1str@t0r3 June 2020
For the past 15 years, industry lobby groups have controlled the use of €3.6 billion in public EU funds for health and climate research through…
@dm1n1str@t0r25 May 2020
;
